Petty Amy J, Yang Yiping
Division of Hematologic Malignancies & Cellular Therapy, Department of Medicine, Duke University Medical Center, Box 103005, Durham, NC 27710, USA.
Department of Immunology, Duke University, Durham, NC 27710, USA.
Immunotherapy. 2017 Mar;9(3):289-302. doi: 10.2217/imt-2016-0135.
Tumor-associated macrophages (TAMs), representing most of the leukocyte population in solid tumors, demonstrate great phenotypic heterogeneity and diverse functional capabilities under the influence of the local tumor microenvironment. These anti-inflammatory and protumorigenic macrophages modulate the local microenvironment to facilitate tumor growth and metastasis. In this review, we examine the origin of TAMs and the complex regulatory networks within the tumor microenvironment that facilitate the polarization of TAMs toward a protumoral phenotype. More extensively, we evaluate the mechanisms by which TAMs mediate angiogenesis, metastasis, chemotherapeutic resistance and immune evasion. Lastly, we will highlight novel interventional strategies targeting TAMs in preclinical studies and in early clinical trials that have significant potential in improving efficacy of current chemotherapeutic and/or immunotherapeutic approaches.
肿瘤相关巨噬细胞(TAM)是实体瘤中白细胞群体的主要组成部分,在局部肿瘤微环境的影响下表现出极大的表型异质性和多样的功能能力。这些抗炎和促肿瘤巨噬细胞调节局部微环境以促进肿瘤生长和转移。在本综述中,我们研究了TAM的起源以及肿瘤微环境中促进TAM向促肿瘤表型极化的复杂调控网络。更广泛地说,我们评估了TAM介导血管生成、转移、化疗耐药和免疫逃逸的机制。最后,我们将重点介绍在临床前研究和早期临床试验中针对TAM的新型干预策略,这些策略在提高当前化疗和/或免疫治疗方法的疗效方面具有巨大潜力。